What is the appropriate approach to managing a 22-year-old female with three months of generalized anxiety, insomnia, and suicidal ideation, who has normal vital signs?

Immediate Suicide Risk Assessment and Psychiatric Referral Required

This 22-year-old female with 3 months of generalized anxiety, insomnia, and suicidal ideation requires immediate comprehensive suicide risk assessment followed by evidence-based psychotherapy, with consideration of pharmacotherapy for both anxiety and insomnia as adjunctive treatment.

Priority 1: Suicide Risk Assessment (Immediate)

The presence of suicidal ideation mandates immediate evaluation before addressing other symptoms 1. Your assessment must include:

• Current suicidal thoughts: Frequency, intensity, duration, and specific plans
• Intent and means: Does she have a plan? Access to lethal means (medications, weapons)?
• Recent behaviors: Any preparatory actions (giving away possessions, saying goodbye)?
• Past suicide attempts: History within last 6 months is critical
• Protective factors: Social support, reasons for living, future orientation
• Current psychiatric symptoms: Severity of anxiety, depression screening (use PHQ-9), psychotic symptoms
• Substance use: Current alcohol or drug use
• Recent stressors: Adverse life events, trauma, relationship problems

Use the Columbia Suicide Severity Rating Scale (C-SSRS) for structured assessment 1, 2. The PHQ-9 item 9 specifically addresses suicidal thoughts and should be administered 2.

Disposition Decision:

• High risk (active plan, intent, means, past attempt): Immediate psychiatric hospitalization or emergency department referral
• Moderate risk (ideation without plan/intent, good support): Outpatient management possible ONLY with robust safety planning and close follow-up 3
• Low risk (passive ideation, strong protective factors): Outpatient management with safety plan

Priority 2: Address Insomnia as Suicide Risk Factor

Insomnia is not merely a symptom here—it's a modifiable proximal risk factor for suicidal ideation 4, 5. The relationship is bidirectional and mechanistically linked through inflammation, neurotransmitter dysregulation, and impaired prefrontal function 5.

Treatment approach for insomnia:

• First-line: Cognitive Behavioral Therapy for Insomnia (CBT-I), including digital formats, which has demonstrated suicidolytic effects—reducing suicidal ideation by 50% through insomnia remission 4
• Pharmacotherapy adjunct: If severe insomnia persists or CBT-I unavailable:
  • Eszopiclone (evidence for GAD-related insomnia) 6
  • Trazodone (if depressive features present) 6
  • Zolpidem-CR showed benefit specifically in suicidal patients with severe insomnia, though effects were modest 7

Critical point: Insomnia remission mediates approximately 50% of suicide risk reduction 4. Treating sleep is not optional—it's a suicide prevention strategy.

Priority 3: Treat Generalized Anxiety Disorder

With 3 months of symptoms, she likely meets GAD criteria. Screen all women aged 13+ for anxiety disorders per 2020 guidelines 2.

Treatment hierarchy:

1. Psychotherapy (Primary): Cognitive Behavioral Therapy focused on suicide prevention is recommended for patients with suicidal ideation 1. Problem-solving based CBT reduces both suicidal ideation and anxiety 1

2. Pharmacotherapy (Adjunctive or if psychotherapy unavailable):

   • SSRIs (paroxetine has specific GAD indication) or SNRIs (venlafaxine) for long-term symptom control 8
   • These also address comorbid depression (present in 56% of GAD cases) 2
   • Avoid benzodiazepines for chronic management—they lose effectiveness long-term and don't address psychic symptoms 8

Priority 4: Screen for Comorbid Depression

Depression and suicidal ideation are strongly linked 9. Administer PHQ-9 immediately 2. If depression is present:

• Depression symptoms predict psychosis risk and suicide more consistently than anxiety alone 9
• Anxiety and depression both fully mediate the insomnia-suicide relationship (62-77% of total effect) 10
• Treat depression concurrently with SSRI/SNRI, which addresses both conditions

Immediate Action Algorithm

If HIGH suicide risk: Emergency psychiatric referral NOW

If MODERATE-LOW risk with adequate support:

1. Week 1:

   • Complete suicide risk assessment with C-SSRS
   • Create documented safety plan (remove lethal means, crisis contacts, coping strategies)
   • Screen with PHQ-9 and GAD-7
   • Refer to CBT therapist specializing in suicide prevention
   • Consider starting SSRI/SNRI (e.g., escitalopram, sertraline)
   • Initiate CBT-I or prescribe sleep medication if severe

2. Week 2-4:

   • Follow-up within 48-72 hours initially, then weekly
   • Reassess suicide risk at each visit
   • Monitor medication response and side effects
   • Ensure psychotherapy engagement

3. Month 2-3:

   • Continue weekly-biweekly monitoring
   • Adjust medications based on response
   • Target insomnia remission as suicide prevention goal

Critical Pitfalls to Avoid

• Don't dismiss suicidal ideation as "just anxiety"—it requires independent assessment and intervention 1
• Don't ignore insomnia—it's a treatable suicide risk factor, not just a symptom 4, 5
• Don't use benzodiazepines chronically for GAD—short-term only if severe, transition to SSRI/SNRI 8
• Don't delay psychotherapy referral—CBT-based approaches are evidence-based for suicide prevention 1
• Don't manage high-risk patients outpatient without robust safety planning and very close follow-up 3

Safety planning alone has insufficient evidence to reduce suicide attempts 1, so it must be combined with active treatment of underlying conditions.